Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 42.08M P/E - EPS this Y - Ern Qtrly Grth -
Income -3.1M Forward P/E - EPS next Y - 50D Avg Chg -18.00%
Sales 557.71k PEG - EPS past 5Y - 200D Avg Chg -16.00%
Dividend N/A Price/Book N/A EPS next 5Y 116.00% 52W High Chg -47.00%
Recommedations - Quick Ratio 0.01 Shares Outstanding 419.52M 52W Low Chg 195.00%
Insider Own 9.42% ROA -89.58% Shares Float 385.53M Beta 0.70
Inst Own 0.06% ROE - Shares Shorted/Prior 1.82M/2.86M Price 0.10
Gross Margin -204.69% Profit Margin - Avg. Volume 168,330 Target Price -
Oper. Margin -179.67% Earnings Date May 10 Volume 93,848 Change -0.74%
About PROVECTUS BIOPHARMACEUTICALS IN

Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes in the United States. The company's lead molecule is rose bengal sodium (RBS). Its clinical development programs include PV-10 for the treatment of stage III and IV melanoma and different types of liver cancers; PH-10 for the treatment of psoriasis and atopic dermatitis, and skin inflammation; and PV-305 for the treatment of infectious keratitis. It is also developing oral formulations for adult solid tumor cancers, as well as refractory and relapsed pediatric, and other blood cancers comprising leukemias; PV-10 for the treatment of relapsed and refractory pediatric solid tumor cancers; and other formulations for the treatment of cutaneous canine cancers and healing of full-thickness cutaneous wounds. In addition, the company develops oral and intranasal formulations for the treatment of severe acute respiratory syndrome coronavirus 2; gram-positive and gram-negative bacterial infections; oral bacterial infections; and fungal infections; as well as vertebrate development, wound healing, and tissue regrowth. It has collaboration agreement with Bascom Palmer Eye Institute; and University of Miami. The company was formerly known as Provectus Pharmaceuticals, Inc. and changed its name to Provectus Biopharmaceuticals, Inc. in December 2013. Provectus Biopharmaceuticals, Inc. was founded in 2002 and is based in Knoxville, Tennessee.

PROVECTUS BIOPHARMACEUTICALS IN News
04/16/24 Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
04/11/24 Provectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC at AACR 2024 Annual Meeting
03/27/24 Provectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miami for Photodynamic Antimicrobial Treatment of Different Eye Infections with Rose Bengal Sodium
03/12/24 Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines
03/07/24 Provectus Biopharmaceuticals Announces Acceptance of Cancer Immunotherapy PV-10 Abstract for HNSCC at AACR 2024 Annual Meeting
02/29/24 Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting
02/23/24 Provectus Biopharmaceuticals, Inc. (PNK:PVCT) Q1 2024 Earnings Call Transcript
02/15/24 Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
02/14/24 Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services
12/18/23 Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as Anticancer and Antiviral Vaccine Adjuvant
11/15/23 Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Advanced Cutaneous Melanoma
11/13/23 Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal Melanoma
11/06/23 Provectus Biopharmaceuticals Announces Presentation of Preclinical PV-10 Vaccine Adjuvant Data at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
08/07/23 Provectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
08/01/23 Provectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentations at Society for Melanoma Research (SMR) 2023 Congress
06/28/23 Provectus Biopharmaceuticals Establishes Research Collaboration with University of Tennessee College of Veterinary Medicine to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal Sodium for Canine Soft Tissue Sarcomas
06/26/23 Provectus Biopharmaceuticals Announces Stockholder Approval to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio
04/20/23 Provectus Biopharmaceuticals Announces Publication of Activity of Pharmaceutical-Grade Rose Bengal Sodium (RBS) Against Colistin-Resistant Gram-Negative Bacteria
PVCT Chatroom

User Image FancyPants Posted - 10/20/16

$PVCT hoping for green close... any green. Even .01%

User Image positivepanda Posted - 10/20/16

@Jim_Rockford NYSE has a 6 cents rule. Look at $PVCT

User Image kempizano Posted - 10/20/16

$PVCT Low volume today not much going on. .05 won't happen today.

User Image 911x50 Posted - 10/20/16

$PVCT

User Image doylejames Posted - 10/20/16

$PVCT Wankers, any idea on this thing moving at some point. Sitting at .075 average. Held through the delist, but it seems dead for now.

User Image bobv50 Posted - 10/20/16

$PVCT This guy has been obsessed & bashing this since February?

User Image bobv50 Posted - 10/20/16

$PVCT Why are you here then? Are you shorting or trolling? 🤔

User Image Michaelpaul1 Posted - 10/20/16

$PVCT delusional investor thread right here...

User Image nay123 Posted - 10/20/16

$PVCT WAAAAAAAANKERS UNITE!

User Image TMoneyTrading Posted - 10/20/16

$PVCT looks like we will not be getting our money back :(

User Image ocarcara Posted - 10/20/16

$PVCT this lol vol at those price is a bit scare.

User Image droppingdimes Posted - 10/20/16

$PVCT this stock got delisted as of today.

User Image ocarcara Posted - 10/20/16

$PVCT getting ready for a,great day!!!!!

User Image TMoneyTrading Posted - 10/19/16

$PVCT hopefully this goes up bigly!

User Image bobv50 Posted - 10/19/16

$PVCT $MGTI That's why I lash out when trolls laugh when a stock collapses. It could happen to any stock @ anytime..karma is a boomerang🙈

User Image Digger12 Posted - 10/19/16

$PVCT actually green now bought enough at 0.02-0.03 to offset everything I had at 0.88. Gains last few days been great see if they continue

User Image zzyxz Posted - 10/19/16

$PVCT $MGTI ouch !

User Image slvrbllt98 Posted - 10/19/16

$PVCT Strong close, guys. I'd be very happy if we're in the .05 - .06 range by EOD Friday.

User Image ospreyeye Posted - 10/19/16

$PVCT Chart - a close above EMA 4 would be bullish putting EMA 8 on deck - chart shows EMA 4 has been resistance -

User Image doylejames Posted - 10/19/16

$PVCT The link is to an article where they were interviewed. The interview is new, we all know what happened with the delisting.

User Image CocoaPuffs Posted - 10/19/16

$PVCT

User Image k_ro Posted - 10/19/16

$PVCT 1 million sell woww

User Image Aristotales Posted - 10/19/16

$PVCT someone has to get down that 30000 @ 0.0490

User Image TheNiteman Posted - 10/19/16

$PVCT Price is showing on RH again!

User Image slvrbllt98 Posted - 10/19/16

$PVCT We all know they're going to vote for RS on November 14th but I wish they wouldn't. They should rely on data results to bump up pps.

User Image zzyxz Posted - 10/19/16

$PVCT they need to be on the NYSE in order to execute another offering "ratchet" all bad ,

User Image killen_em_shortly Posted - 10/19/16

$PVCT one crazy DCB!

User Image michaelconnolly Posted - 10/19/16

$PVCT anyone know when this should be back?

User Image doylejames Posted - 10/19/16

$PVCT http://www.knoxnews.com/story/money/business/2016/10/17/provectus-stock-suspended-nyse/92291594/

User Image JWalkerBeats Posted - 10/19/16

$PVCT